BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bersanelli M, Buti S, Camisa R, Brighenti M, Lazzarelli S, Mazza G, Passalacqua R. Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy. Cancers (Basel) 2014;6:2035-48. [PMID: 25271833 DOI: 10.3390/cancers6042035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Guo F. Recent updates on cancer immunotherapy. Prec Clin Med. 2018;1:65-74. [PMID: 30687562 DOI: 10.1093/pcmedi/pby011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 10.8] [Reference Citation Analysis]
2 Chan CW, Tsui SK, Law BM, So WK, Tang FW, Wong CL. The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy. Int J Mol Sci 2016;17:286. [PMID: 26927069 DOI: 10.3390/ijms17030286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 van den Heuvel MM, Verheij M, Boshuizen R, Belderbos J, Dingemans AM, De Ruysscher D, Laurent J, Tighe R, Haanen J, Quaratino S. NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy. J Transl Med 2015;13:32. [PMID: 25622640 DOI: 10.1186/s12967-015-0397-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 8.6] [Reference Citation Analysis]
4 Jiang T, Zhou C, Ren S. Role of IL-2 in cancer immunotherapy. Oncoimmunology. 2016;5:e1163462. [PMID: 27471638 DOI: 10.1080/2162402x.2016.1163462] [Cited by in Crossref: 168] [Cited by in F6Publishing: 95] [Article Influence: 28.0] [Reference Citation Analysis]
5 Houron C, Danielou M, Mir O, Fromenty B, Perlemuter G, Voican CS. Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians. Crit Rev Oncol Hematol 2021;157:103127. [PMID: 33161366 DOI: 10.1016/j.critrevonc.2020.103127] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Jiang T, Zhou C. The past, present and future of immunotherapy against tumor. Transl Lung Cancer Res 2015;4:253-64. [PMID: 26207213 DOI: 10.3978/j.issn.2218-6751.2015.01.06] [Cited by in F6Publishing: 19] [Reference Citation Analysis]